Cargando…
Breast Cancer in the Transgender Population
ES is a 41-year-old transgender male who presented to medical oncology as a referral from surgical oncology for T2N0M0 right breast cancer. At that time, he was receiving weekly testosterone injections intramuscularly at 0.25 mg, and had been on this regimen for 7 months. He was planning bilateral m...
Autores principales: | Fehl, Andrea, Ferrari, Shannon, Wecht, Zoe, Rosenzweig, Margaret |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520739/ https://www.ncbi.nlm.nih.gov/pubmed/33343986 http://dx.doi.org/10.6004/jadpro.2019.10.4.6 |
Ejemplares similares
-
A Patient-Centered Approach for the Treatment of Fungating Breast Wounds
por: Rupert, Karlyn L., et al.
Publicado: (2020) -
Treatment of Pregnancy-Associated Breast Cancer
por: Labriola, Bernadette
Publicado: (2019) -
A Tale of Two Sisters: Breast Reconstruction Options for Women With or at High Risk of Breast Cancer
por: Trotter, Kathryn, et al.
Publicado: (2020) -
Timely Genetic Testing and Therapy Management in Patients With gBRCA-Mutated Metastatic Breast Cancer Receiving Talazoparib
por: Martinez, Ashley, et al.
Publicado: (2022) -
Pregnancy and breast cancer in a patient with complicated Kawasaki Disease, as if one problem was not enough: a case report
por: Barzen, Gina, et al.
Publicado: (2022)